Bruce D Given
CIK 1219384 · Chief Operating Officer · last filed 2020-04-29
Bruce D Given is a Chief Operating Officer who has filed 27 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for ARWR, was dated Apr 29, 2020. Across all open-market trades the lifetime net is −$14.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $49.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ARWR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 700
HOUSTON, TX 77081
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARWR | Chief Operating Officer | 854,788 | $58.16 | $49.71M | -$14.16M | 26 | 2020-04-29 |
| ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted | President & CEO | 298,174 | — | — | $0 | 1 | 2007-03-16 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-29 | ARWR | Mixed | −1,004 | -$178.9K | EDGAR |
| 2020-04-22 | ARWR | Mixed | −7,259 | -$808.3K | EDGAR |
| 2020-01-08 | ARWR | Sell (S) | −35,613 | -$2.14M | EDGAR |
| 2020-01-03 | ARWR | Grant (A) | +250,000 | $0 | EDGAR |
| 2019-03-01 | ARWR | Mixed | — | -$764.1K | EDGAR |
| 2019-02-27 | ARWR | Mixed | — | -$721.2K | EDGAR |
| 2019-02-20 | ARWR | Mixed | −26,250 | -$1.14M | EDGAR |
| 2019-02-12 | ARWR | Mixed | −177,000 | -$3.75M | EDGAR |
| 2019-02-07 | ARWR | Sell (S) | −22,500 | -$325.8K | EDGAR |
| 2019-02-01 | ARWR | Sell (S) | −28,500 | -$394.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.